Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
A phase 3 trial of Axicabtagene ciloleucel, Cyclophosphamide, Fludarabine in follicular lymphoma, run by Kite, A Gilead Company, active and no longer recruiting.
Overview
Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma is a phase 3 interventional study registered as NCT05371093 by Kite, A Gilead Company, with 231 participants enrolled, started 2022-09-22 and due to reach its primary completion in 2030-10. Interventions recorded: Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine, Lenalidomide, Rituximab. Conditions listed: Relapsed/Refractory Follicular Lymphoma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
Shares Lenalidomide, Rituximab, Cyclophosphamide, Doxorubicin.
- TrialA Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Rela
Shares Lenalidomide, Rituximab, Cyclophosphamide, Doxorubicin.
- TrialSafety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
Shares Lenalidomide, Rituximab, Cyclophosphamide, Doxorubicin.
- TrialA Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
Shares Lenalidomide, Rituximab, Follicular lymphoma.
- TrialStudy of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease
Shares Lenalidomide, Rituximab, Doxorubicin, Follicular lymphoma.
- TrialStudy of KTE-X19 in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma or Relapsed/Refractory B-precursor Acute Lymphoblastic L
Shares Fludarabine, Gilead Sciences (incl. Kite), Cyclophosphamide.
- TrialA Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy
Shares Rituximab, Cyclophosphamide, Doxorubicin, Follicular lymphoma.
- TrialA Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemo
Shares Rituximab, Cyclophosphamide, Doxorubicin, Follicular lymphoma.